Comprehensive Cat Vaccine – Nobivac 1-HCPCh + FeLV

Nobivac Feline 1-HCPCh + FeLV is a very broad-spectrum 5-in-1 vaccine for protection against Feline Rhinotracheitis, Calicivirus, Panleukopenia, Chlamydia psittaci, and Feline Leukemia Virus. This all-in-one vaccine helps prevent serious respiratory infections, gastrointestinal diseases, eye infections, and the life-threatening FeLV that can cause immune suppression and cancer. Recommended for kittens and adult cats, this vaccine is ideal for outdoor cats, multi-cat households, and shelters where FeLV exposure is a risk.

Benefits:

• 5-in-1 Disease Protection – Guards against FVR, FCV, FPV, Chlamydia psittaci, and FeLV.
• Prevents Feline Leukemia (FeLV) – Reduces the risk of FeLV transmission, a major cause of fatal feline diseases.
• Supports Immune Health – Strengthens immunity against respiratory and viral infections.
• Safe for Kittens & Adult Cats – Recommended for high-risk cats under veterinary guidance.
• Ideal for Outdoor & Multi-Cat Environments – Essential for cats exposed to other felines.

NOTICE: This item requires Express shipping due to the perishable nature of this product. Express orders are shipped Monday - Wednesday. Cannot be shipped to a PO box. The product can only be shipped to the continental US. Please note, that it will require a signature upon delivery to ensure the order is received.

Why is the Nobivac Feline 1-HCPCh + FeLV vaccine important for my cat?

This vaccine protects against five major feline diseases, including the Feline Leukemia Virus (FeLV), which is a leading cause of immune suppression and cancer in cats.

How often should my cat receive the Nobivac Feline 1-HCPCh + FeLV vaccine?

Kittens require an initial series with boosters, followed by annual revaccination for FeLV and core vaccines as recommended by a veterinarian.

Dosage & Administration:

Before use, warm the Nobivac® Feline 2-FeLV to room temperature and shake well. Transfer the contents of the Nobivac® Feline 2-FeLV vial to the Nobivac® Feline 1-HCPCh vial aseptically. Mix gently until dissolved.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

The presence of maternal antibodies is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general, or in the face of maternal antibodies, consult your veterinarian or the manufacturer.

Precautions:

• Store at 2° - 8°C (35°-46°F).
• Do not freeze.
• Use new, non-chemically sterilized needles and syringes.
• Do not mix with other products, except as specified on the label.
• Inactivate unused contents before disposal.
• In case of human exposure, contact a physician.

Warnings:

• Contains gentamicin and amphotericin B as preservatives.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following FeLV vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination may not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen before vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus. It is important to advise the cat owner of these situations before vaccination.

Shipping & Returns

• Shipping: Learn more about our flexible shipping options by visiting our Shipping Policies.
• Returns: For assistance with returns or replacements, review our Refund Policy.

FAQ

What does Nobivac Feline 1-HCPCh + FeLV Vaccine protect against?

It is a vaccine used against five major viral infections of cats, such as:

• Feline Herpesvirus Type 1 (Rhinotracheitis)
• Calicivirus
• Panleukopenia (Feline Distemper)
• Chlamydia psittaci
• Feline Leukemia Virus (FeLV)

How is this vaccine administered?

It is injected subcutaneously by a licensed veterinarian.

At what age does this vaccine should be given to kittens?

They should get their first dose at 9 weeks of age, then a booster in 3-4 weeks. Annual revaccination is recommended for FeLV protection.

Why is FeLV protection important for cats?

FeLV depresses the cat's immune system, making them susceptible to life-threatening diseases, including cancer, anemia, and infections. The virus is transmitted through saliva, shared food bowls, and contact with infected cats.

Does my indoor cat need this vaccine?

While indoor cats are at a much lower risk, FeLV can still be contracted through human contact, new pet introductions, or even veterinary visits. If your cat has any potential for exposure, vaccination is highly advised.

How often should my cat receive this vaccination?

After the initial kitten series, an annual FeLV booster is required to keep your cat protected. The HCPCh portion may also need periodic boosters based on recommendations from your vet.